ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Catalyst's long-delayed Firdapse snags FDA nod
fiercepharma
December 05, 2018It took a breakthrough designation, orphan drug status, an embarrassing?up-front rejection?letter and some extra trials, but Catalyst Pharmaceuticals has finally crossed the finish line with Firdapse.
Pharma Sources Insight January 2025
